Kailera Therapeutics, Inc. (KLRA)
Q2-CY2026Q1-CY2026Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014Q2-CY2014
Balance Sheet Date2026-Mar-31
Fiscal PeriodQ1-FY2026
Close Price of Common Stock23.05$
Market Cap of Common Stock2,986,487,264$
QoQ%
YoY%
Common Shares Outstanding129,565,60829,95319,0481
QoQ%432,463.04%57.25%
YoY%2,995,200.00%
Price to Sales
Price to Earnings
Price to Book-
Total Revenue
QoQ%
YoY%
TTM
TTM_QoQ%
TTM_YoY%
Gross Margin
QoQ
YoY
Operating Income(84,660,000$)(20,458,000$)
QoQ%
YoY%(313.82%)
TTM
TTM_QoQ%
TTM_YoY%
Operating Margin
QoQ
YoY
Net Income(78,865,000$)(17,983,000$)
QoQ%
YoY%(338.55%)
TTM
TTM_QoQ%
TTM_YoY%
Profit Margin
QoQ
YoY
Equity to Common Shareholders(432,088,000$)(356,458,000$)(235,238,000$)
QoQ(75,630,000$)
QoQ%(21.22%)
YoY(196,850,000$)
YoY%(83.68%)
Dividends Paid
Additional Paid-In Capital QoQ
Treasury Stock
QoQ
Goodwill
QoQ%
YoY%
Other Intangible Assets
QoQ
Amortization of Intangible Assets
Total Assets624,756,000$692,294,000$
QoQ(67,538,000$)
YoY
Total Liabilities64,480,000$56,388,000$
QoQ8,092,000$
YoY
Current Ratio9.67x12.01x
Total Current Assets530,315,000$557,537,000$
QoQ(27,222,000$)
Total Current Liabilities54,836,000$46,405,000$
QoQ8,431,000$
Debt to Asset Ratio.10x.08x
Long Term Debt
QoQ
YoY
Capital Lease Obligations10,470,000$10,600,000$
Cash and Cash Equivalents111,826,000$160,267,000$101,776,000$
QoQ(48,441,000$)
YoY10,050,000$
Interest Expenses0$0$
Interest Income5,716,000$1,675,000$